2002 Publications

Acharya, A; Diaz-Ortega, JL; Tambini, G; de Quadros, C; Arita, I; (2002) Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine, 20 (27-28). pp. 3332-41. ISSN 0264-410X DOI:10.1016/S0264-410X(02)00296-7

 

Akramuzzaman, SM; Cutts, FT; Hossain, MJ; Wahedi, OK; Nahar, N; Islam, D; Shaha, NC; Mahalanabis, D; (2002) Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh. Bulletin of the World Health Organization, 80 (10). pp. 776-82. ISSN 0042-9686

 

Barreto, ML; Rodrigues, LC; Cunha, SS; Pereira, S; Hijjar, MA; Ichihara, MY; de Brito, SC; Dourado, I; (2002) Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age. Controlled clinical trials, 23 (5). pp. 540-53. ISSN 0197-2456 DOI:10.1016/S0197-2456(02)00216-7

 

Beutels, P; Edmunds, WJ; Antonanzas, F; de Wit, GA; Evans, D; Feilden, R; Fendrick, AM; Ginsberg, GM; Glick, HA; Mast, E; +3 more… (2002) Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.PharmacoEconomics, 20 (1). pp. 1-7. ISSN 1170-7690 DOI: 10.2165/00019053-200220010-00001

 

Black, GF; Weir, RE; Floyd, S; Bliss, L; Warndorff, DK; Crampin, AC; Ngwira, B; Sichali, L; Nazareth, B; Blackwell, JM; +7 more… (2002) BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet, 359 (9315). pp. 1393-1401. ISSN 0140-6736 DOI: 10.1016/S0140-6736(02)08353-8

 

Brisson, M; Edmunds, WJ; (2002) The cost-effectiveness of varicella vaccination in Canada. Vaccine, 20 (7-8). pp. 1113-25. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00437-6

 

Brisson, M; Edmunds, WJ; Gay, NJ; Miller, E; (2002) Varicella vaccine and shingles. JAMA,  287 (17). 2211; author reply 2211-2. ISSN 0098-7484 DOI: 10.1001/jama.287.17.2211

 

Brisson, M; Gay, NJ; Edmunds, WJ; Andrews, NJ; (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine, 20 (19-20). pp. 2500-7. ISSN 0264-410X DOI:10.1016/S0264-410X(02)00180-9

 

Brugha, R; Starling, M; Walt, G; (2002) GAVI, the first steps: lessons for the Global Fund. Lancet, 359 (9304). pp. 435-8. ISSN 0140-6736 DOI: 10.1016/S0140-6736(02)07607-9

 

Carabin, H; Edmunds, WJ; Kou, U; van Den Hof, S; Nguyen, VH; (2002) The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health, 2. p. 22. ISSN 1471-2458 DOI: 10.1186/1471-2458-2-22

 

Edmunds, WJ; Brisson, M; (2002) The effect of vaccination on the epidemiology of varicella zoster virus. The Journal of infection, 44 (4). pp. 211-9. ISSN 0163-4453 DOI: 10.1053/jinf.2002.0988

 

Edmunds, WJ; Brisson, M; Gay, NJ; Miller, E; (2002) Varicella vaccination: a double-edged sword? Communicable Disease and Public Health, 5 (3). pp. 185-6.

 

Edmunds, WJ; Brisson, M; Melegaro, A; Gay, NJ; (2002) The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine, 20 (9-10). pp. 1316-30. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00473-X

 

Floyd, S; Ponnighaus, JM; Bliss, L; Nkhosa, P; Sichali, L; Msiska, G; Fine, PE; (2002) Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. The Journal of infectious diseases, 186 (6). pp. 807-14. ISSN 0022-1899 DOI: 10.1086/342416

 

Garmory, HS; Brown, KA; Titball, RW; (2002) Salmonella vaccines for use in humans: present and future perspectives.FEMS microbiology reviews, 26 (4). pp. 339-53. ISSN 0168-6445 DOI: 10.1016/S0168-6445(02)00113-4

 

Greenwood, B; Alonso, P; (2002) Malaria vaccine trials. Chemical immunology, 80. pp. 366-95. ISSN 1015-0145

 

Hasan, UA; Harper, DR; Wren, BW; Morrow, WJ; (2002) Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E. Vaccine, 20 (9-10). pp. 1308-15. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00475-3

 

Hussain, R; Kaleem, A; Shahid, F; Dojki, M; Jamil, B; Mehmood, H; Dawood, G; Dockrell, HM; (2002) Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. Journal of immunological methods, 264 (1-2). pp. 95-108. ISSN 0022-1759 DOI: 10.1016/S0022-1759(02)00092-3

 

Leake, JA; Kone, ML; Yada, AA; Barry, LF; Traore, G; Ware, A; Coulibaly, T; Berthe, A; Mambu Ma Disu, H; Rosenstein, NE;+6 more… (2002) Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bulletin of the World Health Organization, 80 (5). pp. 342-9. ISSN 0042-9686

 

Moss, WJ; Monze, M; Ryon, JJ; Quinn, TC; Griffin, DE; Cutts, F; (2002) Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clinical infectious diseases , 35 (2). pp. 189-96. ISSN 1058-4838 DOI: 10.1086/341248

 

Mwinga, A; Nunn, A; Ngwira, B; Chintu, C; Warndorff, D; Fine, P; Darbyshire, J; Zumla, A; (2002) Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. Lancet, 360 (9339). pp. 1050-5. ISSN 0140-6736 DOI: 10.1016/S0140-6736(02)11141-X

 

Nathanson, N; Fine, P; (2002) Virology: Poliomyelitis eradication – a dangerous endgame. Science (New York, NY), 296 (5566). pp. 269-270. ISSN 0036-8075 DOI: 10.1126/science.1071207

 

Obaro, SK; Enwere, GC; Deloria, M; Jaffar, S; Goldblatt, D; Brainsby, K; Hallander, H; McInnes, P; Greenwood, BM;McAdam, K; (2002) Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine. The Pediatric infectious disease journal, 21 (10). pp. 940-946. ISSN 0891-3668 DOI: 10.1097/01.inf.0000034245.88174.3c

 

Partidos, CD; Steward, MW; (2002) Mimotopes of viral antigens and biologically important molecules as candidate vaccines and potential immunotherapeutics. Combinatorial chemistry & high throughput screening, 5 (1). pp. 15-27. ISSN 1386-2073 DOI: 10.2174/1386207023330589

 

Rhodes, SD; Hergenrather, KC; Yee, LJ; (2002) Increasing hepatitis B vaccination among young African-American men who have sex with men: Simple answers and difficult solutions. AIDS patient care and STDs, 16 (11). pp. 519-525. ISSN 1087-2914 DOI: 10.1089/108729102761041074

 

Russell, F; Mulholland, K; (2002) Prevention of otitis media by vaccination. Drugs, 62 (10). pp. 1441-5. ISSN 0012-6667 DOI: 10.2165/00003495-200262100-00002

 

Smeeth, L; Hall, AJ; Rodrigues, LC; Cook, C; Fombonne, E; (2002) Autism, bowel inflammation, and measles. Lancet, 359 (9323). pp. 2112-3. ISSN 0140-6736 DOI: 10.1016/S0140-6736(02)08918-3

 

Smeeth, L; Rodrigues, LC; Hall, AJ; Fombonne, E; Smith, PG; (2002) Evaluation of adverse effects of vaccines: the case-control approach. Vaccine, 20 (19-20). pp. 2611-7. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00147-0

 

Stephenson, J; (2002) Will the current measles vaccines ever eradicate measles? Expert review of vaccines, 1 (3). pp. 355-62. ISSN 1476-0584 DOI: 10.1586/14760584.1.3.355

 

Taylor, B; Miller, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J; (2002) Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ (Clinical research ed), 324 (7334). pp. 393-6. ISSN 0959-8138 DOI: 10.1136/bmj.324.7334.393

 

Thomas, SL; Wheeler, JG; Hall, AJ; (2002) Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet, 360 (9334). pp. 678-82. ISSN 0140-6736 DOI: 10.1016/S0140-6736(02)09837-9

 

Trotter, CL; Edmunds, WJ; (2002) Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ, 324 (7341). p. 809. ISSN 0959-535X DOI: 10.1136/bmj.324.7341.809

 

Walt, G; Brugha, R; Starling, M; (2002) Global alliance on vaccines and immunizations – Save the Children UK had concerns about alliance that went further than report did. BMJ, 324 (7343). pp. 974-5. ISSN 1468-5833

 

Whittle, H; Jaffar, S; Wansbrough, M; Mendy, M; Dumpis, U; Collinson, A; Hall, A; (2002) Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ, 325 (7364). p. 569. ISSN 1468-5833 DOI:10.1136/bmj.325.7364.569

 

da Cunha, SS; Rodrigues, LC; Barreto, ML; Dourado, I; (2002) Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine, 20 (7-8). pp. 1106-12. ISSN 0264-410X DOI: 10.1016/S0264-410X(01)00438-8